Ken Griffin Balchem Corp Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$138.5 - $156.63 $221,600 - $250,608	-1,600 Reduced 94.12%	100 $15,000
Q1 2024 May 15, 2024	BUY	$137.06 - $157.27 $191,884 - $220,178	1,400 Added 466.67%	1,700 $263,000
Q4 2023 Feb 14, 2024	SELL	$115.08 - $150.35 $11,508 - $15,035	-100 Reduced 25.0%	300 $44,000
Q3 2023 Nov 14, 2023	BUY	$123.38 - $142.72 $24,676 - $28,544	200 Added 100.0%	400 $49,000
Q2 2023 Aug 14, 2023	SELL	$122.28 - $136.64 $12,228 - $13,663	-100 Reduced 33.33%	200 $26,000
Q1 2023 May 15, 2023	BUY	$117.39 - $142.06 $23,478 - $28,412	200 Added 200.0%	300 $37,000
Q4 2022 Feb 14, 2023	BUY	$120.16 - $142.73 $12,016 - $14,272	100 New	100 $12,000

372

28.3M

267K

5.7K

Ticker BCPC
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 32,120,600
Market Cap $5.71B
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.